SomnoMed Limited reaffirmed earnings guidance for the year 2023. For the period, Company expects revenue growth of 20%, remains unchanged.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.215 AUD | +2.38% | -2.27% | -57.00% |
1st Jan change | Capi. | |
---|---|---|
-57.00% | 18.64M | |
-2.54% | 187B | |
-1.85% | 106B | |
-4.26% | 66.9B | |
+1.39% | 49.45B | |
+16.82% | 48B | |
+4.06% | 40.84B | |
+3.49% | 26.48B | |
+0.65% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- SOM Stock
- News SomnoMed Limited
- SomnoMed Limited Reaffirms Earnings Guidance for the Year 2023